Form 4: Medpace Holdings Insider Trades Common Stock

Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., reported transactions involving the acquisition and disposition of common stock.

Summary

• Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., executed a series of transactions on May 28, 2026.
• Ewald acquired 16,349 shares of common stock at a price of $138.87 per share.
• Concurrently, Ewald disposed of 16,349 shares of common stock at a price of $450 per share.
• Following these transactions, Ewald beneficially owns 20,343 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions rather than significant company performance or strategic changes.

Positives

• The acquisition of shares at a lower price ($138.87) could be seen as a positive indicator of the executive's belief in the company's future value.
• The executive's continued ownership of 20,343 shares indicates ongoing commitment to the company.

Negatives

• The disposition of 16,349 shares at a significantly higher price ($450) suggests a realization of profit by the reporting person.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal strategic shifts. The reported transactions reflect an executive managing their personal holdings, which is common practice.

Stakeholder Impact

• Shareholders: The filing provides transparency into insider activity, which can influence investor perception but does not directly alter company operations or value.

Key Dates

Keywords

Medpace Holdings, MEDP, Form 4, Insider Trading, Common Stock, Stephen P. Ewald, Securities Exchange Act